A detailed history of Allworth Financial LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Allworth Financial LP holds 2,645 shares of EXAS stock, worth $180,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,645
Previous 2,730 3.11%
Holding current value
$180,812
Previous $188,000 40.96%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$41.33 - $74.26 $3,513 - $6,312
-85 Reduced 3.11%
2,645 $111,000
Q1 2024

Apr 25, 2024

BUY
$56.27 - $73.77 $2,757 - $3,614
49 Added 1.83%
2,730 $188,000
Q4 2023

Jan 24, 2024

BUY
$59.06 - $75.72 $8,918 - $11,433
151 Added 5.97%
2,681 $198,000
Q2 2023

Jul 18, 2023

BUY
$62.68 - $95.05 $313 - $475
5 Added 0.2%
2,530 $237,000
Q1 2023

Apr 18, 2023

SELL
$47.19 - $70.77 $849 - $1,273
-18 Reduced 0.71%
2,525 $171,000
Q4 2022

Jan 13, 2023

BUY
$30.35 - $53.15 $2,185 - $3,826
72 Added 2.91%
2,543 $0
Q3 2022

Oct 18, 2022

BUY
$31.97 - $49.37 $13,331 - $20,587
417 Added 20.3%
2,471 $80,000
Q2 2022

Jul 13, 2022

BUY
$35.61 - $76.23 $1,780 - $3,811
50 Added 2.5%
2,054 $81,000
Q1 2022

Apr 22, 2022

SELL
$57.56 - $82.54 $10,303 - $14,774
-179 Reduced 8.2%
2,004 $140,000
Q4 2021

Jan 21, 2022

BUY
$72.5 - $100.68 $13,267 - $18,424
183 Added 9.15%
2,183 $170,000
Q1 2021

Apr 29, 2021

BUY
$116.57 - $155.01 $231,391 - $307,694
1,985 Added 13233.33%
2,000 $264,000
Q4 2020

Jan 26, 2021

BUY
$99.61 - $142.12 $1,494 - $2,131
15 New
15 $2,000
Q2 2020

Jul 24, 2020

SELL
$55.75 - $92.75 $111,500 - $185,500
-2,000 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$37.9 - $104.44 $75,800 - $208,880
2,000 New
2,000 $116,000
Q1 2019

May 07, 2019

SELL
$61.98 - $96.5 $59,190 - $92,157
-955 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$56.04 - $82.66 $42,310 - $62,408
755 Added 377.5%
955 $60,000
Q3 2018

Oct 30, 2018

BUY
$48.29 - $80.6 $9,658 - $16,119
200 New
200 $16,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.